美股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Gemphire Therapeutics Inc.

0.3000

0.0000

成交量：- -

成交額：- -

市值：446.17萬

市盈率：-0.31

高：0.3000

開：0.3000

低：0.3000

收：0.3000

52周最高：1.49

52周最低：0.2380

股本：1,487.24萬

流通股本：1,028.40萬

量比：- -

換手率：- -

股息：- -

股息率：- -

每股收益(TTM):-0.9678

每股收益(LYR):-1.7121

淨資產收益率：-280.97%

總資產收益率：-44.90%

市淨率：2.27

市盈率(LYR):-0.18

資料載入中...

總覽公司新聞資訊公告

公司資料

公司名字：

Gemphire Therapeutics Inc.

交易所：

NASDAQ

成立時間：

- -

員工人數：

- -

公司地址：

- -

官網：

http://www.gemphire.com

郵編：

- -

電話：

- -

傳真：

- -

簡介：

Gemphire Therapeutics Inc.於2008年11月10日在密歇根以Michigan Life Therapeutics, LLC (MLT)這個名字註冊成立。公司是一家臨床階段的生物製藥公司，致力於將用於治療血脂異常，即一種會增加威脅生命的心血管疾病風險的嚴重的疾病療法的研究開發和商業化。

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎證券香港 | 輕鬆買賣美股港股A股/美債/ETF/Crypto/期權期貨","description":"老虎證券香港提供多種優惠: 港股&Crypto 0佣、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投，即時串流報價與多種工具，立即開戶享更多優惠！","keywords":"老虎證券,老虎證券開戶,老虎證券香港,老虎證券投資,老虎證券美股,老虎證券登錄,證券開戶,證券公司開戶,股票開戶,香港證券公司,香港證券,證券公司,美股投資平台,小額投資理財,投資app,投資平台,股票買賣,買賣股票平台,炒股app,證券app,新手投資","social":{"ogDescription":"老虎證券香港提供多種優惠: 港股&Crypto 0佣、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投，即時串流報價與多種工具，立即開戶享更多優惠！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/GEMP/company"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"GEMP","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"GEMP\",,,,,undefined,":{"symbol":"GEMP","market":"US","secType":"STK","nameCN":"Gemphire Therapeutics Inc.","latestPrice":0.3,"timestamp":1577739600000,"preClose":0.3,"halted":8,"volume":0,"delay":0,"changeRate":0,"floatShares":10283980,"shares":14872411,"eps":-0.967778,"marketStatus":"盤前交易","change":0,"latestTime":"03-24 05:52:40 EDT","open":0.3,"high":0.3,"low":0.3,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.967778,"tradingStatus":1,"nextMarketStatus":{"tag":"開盤","tradingStatus":2,"beginTime":1774359000000},"marketStatusCode":1,"symbolChange":{"newSymbol":"NRBO","executeDate":"2019-12-31"},"adr":0,"adrRate":0,"listingDate":1470369600000,"exchange":"NASDAQ","adjPreClose":0.3,"volumeRatio":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"GEMP\",,,,,undefined,":{"symbol":"GEMP","floatShares":10283980,"roa":"-44.90%","roe":"-280.97%","lyrEps":-1.712137,"shares":14872411,"dividePrice":0,"high":0.3,"amplitude":0,"preClose":0.3,"low":0.3,"week52Low":0.238,"pbRate":"2.27","week52High":1.485,"institutionHeld":0,"latestPrice":0.3,"eps":-0.967778,"divideRate":0,"volume":0,"delay":0,"ttmEps":-0.967778,"open":0.3},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/GEMP\",params:#limit:5,,,undefined,":[{"market":"US","date":"2019-12-31","symbol":"GEMP","oldSymbol":"GEMP","newSymbol":"NRBO","exchange":"NASDAQ","type":"symbolChange","dateTimestamp":1577768400000},{"market":"US","date":"2019-12-31","symbol":"GEMP","type":"split","dateTimestamp":1577768400000,"forFactor":25,"toFactor":1,"ratio":25},{"market":"US","date":"2019-08-09","symbol":"GEMP","fiscalQuarterEnding":"2019/06","expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1565323200000,"reportTimeType":"","actualEps":-0.2},{"market":"US","date":"2019-05-09","symbol":"GEMP","fiscalQuarterEnding":"2019/03","expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1557374400000,"reportTimeType":"","actualEps":-0.27},{"market":"US","date":"2019-03-15","symbol":"GEMP","fiscalQuarterEnding":"2018/12","expectedEps":-0.39,"name":null,"time":"","type":"earning","dateTimestamp":1552622400000,"reportTimeType":"","actualEps":-0.26}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"GEMP\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"GEMP\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{},"stockCompanyDetail":{"websiteUrl":"http://www.gemphire.com","stockEarnings":[{"period":"1week","weight":0},{"period":"1month","weight":0},{"period":"3month","weight":0},{"period":"6month","weight":0},{"period":"1year","weight":0},{"period":"ytd","weight":0}],"compareEarnings":[{"period":"1week","weight":-0.0204},{"period":"1month","weight":-0.0494},{"period":"3month","weight":-0.0474},{"period":"6month","weight":-0.0087},{"period":"1year","weight":0.1621},{"period":"ytd","weight":-0.0389}],"compareStock":{"symbol":"SPY","name":"標普500ETF"},"description":"Gemphire Therapeutics Inc.於2008年11月10日在密歇根以Michigan Life Therapeutics, LLC (MLT)這個名字註冊成立。公司是一家臨床階段的生物製藥公司，致力於將用於治療血脂異常，即一種會增加威脅生命的心血管疾病風險的嚴重的疾病療法的研究開發和商業化。","exchange":"NASDAQ","name":"Gemphire Therapeutics Inc.","nameEN":"Gemphire Therapeutics"}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"GEMP\",market:\"US\",,,undefined,":null}}